Success rate of Orlistat in primary-care practice is limited by failure to follow prescribing recommendations: the referral letter content vs clinical reality Numerous referrals to our Obesity Unit state that 'treatment with Orlistat did not work'. This surprised us, since Orlistat has been well documented to result in long-term sustained moderate weight loss. A simple questionnaire to 70 such patients, however, revealed that in many cases the referral physician had not observed basic rules and regulations, nor given appropriate information on Orlistat use.
effects can be demonstrated in multicentre trials, where specialists and well-trained staff have advanced experience of using such drugs and also are trained to manage obese patients with all their problems. It is fully realised that for the busy practising physician who has to care for his obese patients among many others with chronic conditions, the chances to give these patients the attention they may need and deserve is difficult and challenging. That Orlistat does work in long-term studies in primary health-care settings has actually been described by Lindgärde. 6 Running one of the few obesity units in Sweden, we receive numerous letters of referral, which mirror the stage of development in which many practitioners are. We were earlier disturbed by the fact that the low level of competence in basic knowledge regarding obesity identification lead to letters of referral for obesity, where not even weight, height and certainly not BMI were even mentioned. 7 We are happy to notice that over the last 2 years that practice has improved dramatically in the great Stockholm metropolitan area, indicating that over a short period of time our practitioners have understood the need to engage more in detail in these patients. Recently, Womble et al 8 described the frustration these authors felt when they tried to prescribe long-term medication for weight loss maintenance after a successful initial treatment period. They state the obvious that the 'weight loss medications only work if patients take them long term'. Likewise, we have been frustrated by the fact that many letters to our unit these days start with the opening sentence 'Xenical does not work'.
We decided to send a simple questionnaire to 70 consecutive patients referred to us and on our waiting list in an attempt to elucidate why 'Xenical did not work'. Table 1 describes the clinical characteristics of these patients and Table 2 describes some of our findings. It becomes clear that the information to the patient to facilitate weight loss, concomitant with Orlistat medication, was only given in few cases. It also became obvious that in many cases, patients have not been checked whether they managed to lose the 2.5 kg required by the European authorities to be eligible for future Orlistat treatment, nor that the 5% ensuing weight loss expected during the following 3 months were properly monitored. Table 2 further describes severe shortcomings in 
